Dexlansoprazole

Apo-Dexlansoprazole

30 MG Capsule (Delayed-Release)CanadaMarketedAuthorised 26 Feb 2024

In other countries

The same active substances on other registers, the same brand first.

Dexilant®Serbia · 60mg · kapsula sa modifikovanim oslobađanjem, tvrda · Takeda DOOSame form
Dexilant®Serbia · 30mg · kapsula sa modifikovanim oslobađanjem, tvrda · Takeda DOOSame form
INSTIGAR 30 mg Delayed-Release CapsuleSaudi Arabia · Arab Pharmaceutical ManufacturingSame form
INSTIGAR 30 mg Delayed-Release CapsuleSaudi Arabia · TakedaSame form
INSTIGAR 30 mg Delayed-Release CapsuleSaudi Arabia · Takeda GMBHSame form
DEXILANT DELAYED RELEASE CAPSULE 30mgSingapore · 30mg · capsule, delayed release · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dexlansoprazole

Apo-Dexlansoprazole

30 MG Capsule (Delayed-Release)CanadaMarketedAuthorised 26 Feb 2024

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

DEXILANT DELAYED RELEASE CAPSULE 60mgSingapore · 60mg · capsule, delayed release · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.

DexilantUnited States · 30MG, 60MG · capsule, delayed release · Takeda Pharms USA

DexlansoprazoleUnited States · 30MG, 60MG · capsule, delayed release · Mylan

DexilantBrazil · Takeda Pharma Ltda.

dexlansoprazolBrazil · Viatris Farmaceutica do Brasil Ltda

FrosivBrazil · Viatris Farmaceutica do Brasil Ltda

Dexilant SolutabUnited States · 30MG · tablet, orally disintegrating, delayed release · Takeda Pharms USA

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Dexlansoprazole
Strength: 30 MG
Dosage form: Capsule (Delayed-Release)
Route: Nasogastric, Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 26 Feb 2024
Registration: DIN 02528991
Marketing authorisation holder: Apotex INC
ATC code: A02BC06
Group: Alimentary tract and metabolism
Supply: PRESCRIPTION

DexilantDexlansoprazole · 60 MG · Capsule (Delayed-Release)Canada

DexlansoprazoleDexlansoprazole · 60 MG · Capsule (Delayed-Release)CanadaCancelled

DexlansoprazoleDexlansoprazole · 30 MG · Capsule (Delayed-Release)CanadaCancelled